EMR saw its Momentum Indicator move above the 0 level on October 27, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 91 similar instances where the indicator turned positive. In 58 of the 91 cases, the stock moved higher in the following days. The odds of a move higher are at 64%.
Following a +2.70% 3-day Advance, the price is estimated to grow further. Considering data from situations where EMR advanced for three days, in 219 of 345 cases, the price rose further within the following month. The odds of a continued upward trend are 63%.
The Aroon Indicator entered an Uptrend today. In 156 of 274 cases where EMR Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 57%.
The 10-day RSI Indicator for EMR moved out of overbought territory on October 30, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 42 similar instances where the indicator moved out of overbought territory. In 20 of the 42 cases, the stock moved lower in the following days. This puts the odds of a move lower at 48%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 37 of 60 cases where EMR's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 62%.
The Moving Average Convergence Divergence Histogram (MACD) for EMR turned negative on November 05, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 44 similar instances when the indicator turned negative. In 25 of the 44 cases the stock turned lower in the days that followed. This puts the odds of success at 57%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where EMR declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 56%.
EMR broke above its upper Bollinger Band on October 27, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron Profit vs. Risk Rating rating for this company is 16 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 73, placing this stock better than average.
The Tickeron Price Growth Rating for this company is 27 (best 1 - 100 worst), indicating outstanding price growth. EMR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 32 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron SMR rating for this company is 62 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 81 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.444) is normal, around the industry mean (3.843). P/E Ratio (35.370) is within average values for comparable stocks, (36.971). Projected Growth (PEG Ratio) (1.837) is also within normal values, averaging (1.879). Dividend Yield (0.014) settles around the average of (0.032) among similar stocks. P/S Ratio (4.409) is also within normal values, averaging (189.487).
FLS moved above its 50-day moving average on October 29, 2026 date and that indicates a change from a downward trend to an upward trend. In 36 of 45 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 80%.
The Momentum Indicator moved above the 0 level on October 28, 2026. You may want to consider a long position or call options on FLS as a result. In 59 of 82 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 72%.
The Moving Average Convergence Divergence (MACD) for FLS just turned positive on October 27, 2026. Looking at past instances where FLS's MACD turned positive, the stock continued to rise in 35 of 44 cases over the following month. The odds of a continued upward trend are 80%.
The 10-day moving average for FLS crossed bullishly above the 50-day moving average on November 04, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 11 of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 69%.
Following a +9.98% 3-day Advance, the price is estimated to grow further. Considering data from situations where FLS advanced for three days, in 255 of 347 cases, the price rose further within the following month. The odds of a continued upward trend are 73%.
The RSI Indicator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 9 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
The 50-day moving average for FLS moved below the 200-day moving average on October 14, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where FLS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 59%.
FLS broke above its upper Bollinger Band on October 29, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for FLS entered a downward trend on October 28, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron PE Growth Rating for this company is 13 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 19 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 73, placing this stock better than average.
The Tickeron Price Growth Rating for this company is 39 (best 1 - 100 worst), indicating steady price growth. FLS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 52 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 76 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.521) is normal, around the industry mean (3.843). P/E Ratio (27.810) is within average values for comparable stocks, (36.971). Projected Growth (PEG Ratio) (1.585) is also within normal values, averaging (1.879). Dividend Yield (0.011) settles around the average of (0.032) among similar stocks. P/S Ratio (2.015) is also within normal values, averaging (189.487).
EMR | FLS | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 30 | 39 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 81 Overvalued | 76 Overvalued | |
PROFIT vs RISK RATING 1..100 | 16 | 19 | |
SMR RATING 1..100 | 62 | 52 | |
PRICE GROWTH RATING 1..100 | 27 | 39 | |
P/E GROWTH RATING 1..100 | 32 | 13 | |
SEASONALITY SCORE 1..100 | 50 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
FLS's Valuation (76) in the Industrial Machinery industry is in the same range as EMR (81) in the Electrical Products industry. This means that FLS’s stock grew similarly to EMR’s over the last 12 months.
EMR's Profit vs Risk Rating (16) in the Electrical Products industry is in the same range as FLS (19) in the Industrial Machinery industry. This means that EMR’s stock grew similarly to FLS’s over the last 12 months.
FLS's SMR Rating (52) in the Industrial Machinery industry is in the same range as EMR (62) in the Electrical Products industry. This means that FLS’s stock grew similarly to EMR’s over the last 12 months.
EMR's Price Growth Rating (27) in the Electrical Products industry is in the same range as FLS (39) in the Industrial Machinery industry. This means that EMR’s stock grew similarly to FLS’s over the last 12 months.
FLS's P/E Growth Rating (13) in the Industrial Machinery industry is in the same range as EMR (32) in the Electrical Products industry. This means that FLS’s stock grew similarly to EMR’s over the last 12 months.
| EMR | FLS | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 48% | 1 day ago 63% |
| Stochastic ODDS (%) | 1 day ago 62% | 1 day ago 61% |
| Momentum ODDS (%) | 1 day ago 64% | 1 day ago 72% |
| MACD ODDS (%) | 1 day ago 57% | 1 day ago 80% |
| TrendWeek ODDS (%) | 1 day ago 62% | 1 day ago 74% |
| TrendMonth ODDS (%) | 1 day ago 56% | 1 day ago 69% |
| Advances ODDS (%) | 8 days ago 63% | 3 days ago 73% |
| Declines ODDS (%) | 6 days ago 56% | 23 days ago 59% |
| BollingerBands ODDS (%) | 1 day ago 57% | 1 day ago 58% |
| Aroon ODDS (%) | 1 day ago 57% | 1 day ago 50% |
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
EMR’s FA Score shows that 3 FA rating(s) are green while FLS’s FA Score has 2 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
EMR’s TA Score shows that 3 TA indicator(s) are bullish while FLS’s TA Score has 5 bullish TA indicator(s).
EMR (@Industrial Machinery) experienced а +0.69% price change this week, while FLS (@Industrial Machinery) price change was +5.71% for the same time period.
The average weekly price growth across all stocks in the @Industrial Machinery industry was +3.26%. For the same industry, the average monthly price growth was -8.83%, and the average quarterly price growth was -16.17%.
EMR is expected to report earnings on Feb 10, 2027.
FLS is expected to report earnings on Feb 23, 2027.
The industry makes and maintains machines for consumers, the industry, and most other companies. While it has traditionally been categorized as heavy industry, some smaller companies are also branching into the light category. The industry is pivotal in providing the equipment for production in businesses like agriculture, mining, industry and construction, gas, electricity and water utilities. It also supplies supporting equipment for almost all sectors of the economy, such as equipment for heating, and air conditioning of buildings. Illinois Tool Works Inc., Parker-Hannifin Corporation and Rockwell Automation Inc are some of the major U.S. companies operating in this industry.
A.I.dvisor indicates that over the last year, FLS has been closely correlated with FELE. These tickers have moved in lockstep 69% of the time. This A.I.-generated data suggests there is a high statistical probability that if FLS jumps, then FELE could also see price increases.
| Ticker / NAME | Correlation To FLS | 1D Price Change % | ||
|---|---|---|---|---|
| FLS | 100% | -0.20% | ||
| FELE - FLS | 69% Closely correlated | +0.76% | ||
| ATMU - FLS | 65% Loosely correlated | +0.51% | ||
| LECO - FLS | 62% Loosely correlated | -0.01% | ||
| KMT - FLS | 62% Loosely correlated | -0.62% | ||
| EMR - FLS | 61% Loosely correlated | -1.17% | ||
More | ||||
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| XLV | 188.88 | 0.55 | +0.29% |
| State Street Health Care Select Sector SPDR ETF (XLV) | |||
| BFOR | 23.17 | -0.03 | -0.13% |
| ALPS Barron's 400 ETF (BFOR) | |||
| BKF | 39.21 | -0.09 | -0.23% |
| iShares MSCI BIC ETF (BKF) | |||
| MYCH | 24.59 | -0.07 | -0.28% |
| State Street My2028 Corporate Bond ETF (MYCH) | |||
| PYPG | 8.42 | -0.39 | -4.40% |
| Leverage Shares 2X Long PYPL Daily ETF (PYPG) | |||